By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

arGEN-X 

Dr Molewaterplein 50

Rotterdam    3015 GE  The Nederlands
Phone: 31-0-10-7038441 Fax: 31-0-10-7038440


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Forbion Announces Closing Of Initial Public Offering Of Portfolio Company arGEN-X 7/9/2014 9:09:43 AM
Dutch Biotech arGEN-X Plans To Go Public In Brussels 6/10/2014 7:26:33 AM
arGEN-X Inks Long-Term Alliance With Shire Pharmaceuticals (SHPG) Worth $20.4 Million 6/4/2014 6:31:23 AM
arGEN-X Uses Its Simple Antibody™ Platform To Identify Four "Hotspots" On MET As Targets For Its Therapeutic Antibody Program 4/7/2014 9:23:05 AM
arGEN-X Raises EUR 5 Million From PMV in Extension of EUR 32.5 Million Series B 11/4/2013 9:25:36 AM
arGEN-X and de Duve Institute at the Catholique University of Louvain to Collaborate on Novel Immunomodulation Therapy in Cancer 11/4/2013 9:23:48 AM
arGEN-X Reaches Milestone in Simple Antibody™ Research and Product Development Collaboration With Shire Pharmaceuticals (SHPG) 9/19/2013 10:00:42 AM
arGEN-X Initiates Phase IbStudy of ARGX-111 in Cancer 9/17/2013 9:05:24 AM
arGEN-X Identifies Potent Antibody Antagonists Against Complex Chronic Pain Target Nav1.7 9/12/2013 9:24:28 AM
arGEN-X Grants Licenses to Its NHance™ Antibody Half-Life Extension Technology 8/6/2013 9:39:06 AM
123
//-->